Cystic Fibrosis Transmembrane Conductance Regulator–associated ATP Release Is Controlled by a Chloride Sensor by Jiang, Qinshi et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/98/11/645/13 $2.00
The Journal of Cell Biology, Volume 143, Number 3, November 2, 1998 645Ð657
http://www.jcb.org 645
 
Cystic Fibrosis Transmembrane Conductance RegulatorÐassociated
ATP Release Is Controlled by a Chloride Sensor
 
Qinshi Jiang,* Daniel Mak,
 
¤
 
 Sreenivas Devidas,
 
i
 
 Erik M. Schwiebert,
 
¦ 
 
Alvina Bragin,
 
à
 
 Yulong Zhang,* 
William R. Skach,
 
à
 
 William B. Guggino,
 
i
 
 
 
J. Kevin Foskett,
 
¤
 
 and John F. Engelhardt
 
¤
 
*Department of Anatomy and Cell Biology, University of Iowa, Iowa City, Iowa 52242-1109; 
 
à
 
Institute for Human Gene 
Therapy and Department of Molecular and Cellular Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104; 
 
¤
 
Institute for Human Gene Therapy and Department of Physiology, University of Pennsylvania, Philadelphia, Pennsylvania 
19104; 
 
i
 
Department of Physiology and Medicine Divisions of Pediatrics and Nephrology, and Center for Medical Genetics, Johns 
Hopkins University School of Medicine and Johns Hopkins Hospital, Baltimore, Maryland 21205; and 
 
¦
 
Department of 
Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama 35294
 
Abstract. 
 
The cystic fibrosis transmembrane conduc-
tance regulator (CFTR) is a chloride channel that is de-
fective in cystic fibrosis, and has also been closely asso-
ciated with ATP permeability in cells. Using a 
 
Xenopus 
 
oocyte cRNA expression system, we have evaluated the 
molecular mechanisms that control CFTR-modulated 
ATP release. CFTR-modulated ATP release was de-
pendent on both cAMP activation and a gradient 
change in the extracellular chloride concentration. Ac-
tivation of ATP release occurred within a narrow con-
centration range of external Cl
 
2
 
 that was similar to that 
reported in airway surface fluid. Mutagenesis of CFTR 
demonstrated that Cl
 
2
 
 conductance and ATP release 
regulatory properties could be dissociated to different 
regions of the CFTR protein. Despite the lack of a need 
for Cl
 
2
 
 conductance through CFTR to modulate ATP 
release, alterations in channel pore residues R347 and 
R334 caused changes in the relative ability of different 
halides to activate ATP efflux (wtCFTR, Cl
 
 .. 
 
Br; 
R347P, Cl
 
 .. 
 
Br; R347E, Br
 
 .. 
 
Cl; R334W, Cl
 
 5 
 
Br). We hypothesize that residues R347 and R334 may 
contribute a Cl
 
2 
 
binding site within the CFTR channel 
pore that is necessary for activation of ATP efflux in re-
sponse to increases of extracellular Cl
 
2
 
. In summary, 
these findings suggest a novel chloride sensor mecha-
nism by which CFTR is capable of responding to 
changes in the extracellular chloride concentration by 
modulating the activity of an unidentified ATP efflux 
pathway. This pathway may play an important role in 
maintaining fluid and electrolyte balance in the airway 
through purinergic regulation of epithelial cells. Insight 
into these molecular mechanisms enhances our under-
standing of pathogenesis in the cystic fibrosis lung.
Key words: CFTR ¥ ATP release ¥ Cl
 
2
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FTR is a member of the ATP-binding cassette
(ABC)
 
1
 
 superfamily that includes over thirty pro-
teins that share extensive sequence similarity and
domain organization (Higgins et al., 1990; Ames et al.,
1986; Hyde et al., 1990). Electrophysiologic analyses of the
CFTR gene product has demonstrated that it is a cAMP-
activated chloride channel with a conductance of 7Ð10 pS
(Drumm et al., 1990; Gregory et al., 1990; Kartner et al.,
1990; Anderson et al., 1991; Bear et al., 1992). Although
altered Cl
 
2
 
 permeability through CFTR has generally
been accepted to play a role in the pathogenesis of cystic
fibrosis (CF), it remains unclear whether this defect alone
can explain the complex pathophysiology of associated
lung disease. Recent studies have indicated that in addi-
tion to its well-defined Cl
 
2
 
 channel activity, CFTR is also a
regulator of other epithelial ion channels, including an
outwardly rectifying Cl
 
2
 
 channel (ORCC; Egan et al.,
1992; Gabriel et al., 1993; Schwiebert et al., 1995; Schwie-
bert et al., 1998; Jovov et al., 1995), the epithelial Na
 
1
 
channel (ENaC; Grubb et al., 1994; Chinet et al., 1994;
Johnson
 
 
 
et al., 1995; Hyde
 
 
 
et al., 1993; Ismailov
 
 
 
et al., 1996;
Stutts et al.,
 
 
 
1997; Kunzelmann et al.,
 
 
 
1997), and a kidney
K
 
1
 
 channel (ROMK; McNicholas
 
 
 
et al.,
 
 
 
1996; McNicholas
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1.
 
 Abbreviations used in this paper
 
: ABC, ATP-binding cassette; CF, cystic
fibrosis; ORCC, outwardly rectifying Cl
 
2 
 
channel; TEV, two-electrode
voltage clamp; 
 
V
 
m
 
, transmembrane potential; W
 
c
 
, whole cell.
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et al., 1997; Ho, 1998). However, the mechanisms by which
these regulatory functions contribute to the maintenance
of airway electrolyte and fluid balance remain obscure.
Cantiello and colleagues first suggested that the multi-
drug resistance protein, a member of the ABC superfam-
ily, might conduct ATP (Abraham
 
 
 
et al., 1993). Several
groups have provided evidence that CFTR also plays a
role in ATP release (Reisin
 
 
 
et al., 1994; Schwiebert et al.,
1995; Prat
 
 
 
et al., 1996; Pasyk and Foskett, 1997; Sugita et al.,
1998, Cantiello et al., 1998). Guggino and colleagues sug-
gested that CFTR stimulates the ORCC via a P
 
2
 
U puriner-
gic receptorÐdependent signal transduction pathway by
modulating ATP efflux (Schwiebert
 
 
 
et al., 1995). Similar
mechanisms of ion channel regulation have been proposed
for other ABC transporters that secrete ATP (Al-Awqati,
1995). However, several laboratories have failed to ob-
serve an association of CFTR with ATP permeability
(Reddy
 
 
 
et al., 1996; Li
 
 
 
et al., 1996; Grygorczyk
 
 
 
et al., 1996).
In model systems that have been able to demonstrate
CFTR-modulated ATP release, it is presently unclear
whether CFTR itself, another unknown cofactor, or a
CFTR-linked biologic process such as exocytosis, repre-
sents the ATP permeation/release pathway. It is also un-
known if dysregulation of this process contributes to CF
lung disease progression. Most recently, Foskett and co-
workers demonstrated that ATP channels exhibiting slow
gating kinetics were associated within a subpopulation of
CFTR Cl
 
2
 
 channels in MDCK cells (Sugita et al., 1998).
They concluded that phosphorylation- and nucleotide hy-
drolysisÐdependent CFTR gating is directly involved in
gating an associated ATP channel, but that the permeation
pathways for Cl
 
2 
 
and ATP are distinct. Because the ATP
conduction pathway did not appear to be obligatorily asso-
ciated with CFTR expression, they suggested the existence
of a cofactor that may mediate CFTR-regulated ATP con-
ductance. However, a recent report reconstituting purified
CFTR into lipid bilayers has suggested that CFTR enables
permeation of both Cl
 
2 
 
and ATP (Cantiello et al., 1998).
In the present study, we used a 
 
Xenopus 
 
oocyte cRNA
expression system coupled with a sensitive luciferinÐ
luciferase bioluminescence assay to explore the mecha-
nisms that control CFTR-modulated ATP release. Our
results suggest that expression of CFTR can confer a Cl
 
2
 
-
sensitive ATP permeability to injected oocytes. Muta-
tional analysis suggests that the interaction of extracellular
Cl
 
2
 
 at arginine residues R334 and R347 within the channel
pore controls the ability of CFTR to modulate ATP re-
lease. These results suggest a novel mechanism by which
changes in the extracellular Cl
 
2 
 
concentration participate
in the activation of CFTR-modulated ATP release.
 
Materials and Methods
 
Xenopus Oocyte Isolation and Maintenance
 
Adult female 
 
Xenopus laevis
 
 were obtained from NASCO (Fort Atkin-
son, WI) and 
 
Xenopus
 
-1 (Ann Arbor, Michigan). Immediately before sur-
gery, frogs were anaesthetized by immersion in 0.17% (wt/vol) tricaine
(3-aminobenzoic acid ethyl ester methanesulphonate) for 5 min, and were
then cooled by adding an equal volume of ice to the Tricaine solution for
10 min. Ovaries were surgically removed from anaesthetized frogs
through a small incision in the lower abdomen.
 
 
 
Individual oocytes were
isolated and defolliculated by collagenase treatment. In brief, isolated oo-
cytes were rinsed in Ca
 
2
 
1
 
-free SOS (100 mM NaCl, 2 mM KCl, 1 mM
MgCl
 
2
 
, and 5 mM Hepes-NaOH, pH 7.6) and incubated with Type IV col-
lagenase (2.0 mg/ml; Sigma Chemical Co., St. Louis, MO) in the same me-
dia for 45 min with gentle shaking. After rinsing several times with Ca
 
2
 
1
 
-
free SOS, defolliculated oocytes were kept in SOS (100 mM NaCl, 2 mM
KCl, 1.8 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, 5 mM Hepes, pH 7.6) supplemented
with 2.5 mM sodium pyruvate and 50 
 
m
 
g/ml gentamycin at 16
 
8
 
C until used.
During the course of this study, we found that only 
 
z
 
10% of the frogs
had oocytes that displayed CFTR-modulated ATP release, despite their
ability to generate CFTR-dependent cAMP-inducible Cl
 
2
 
 currents. We
therefore screened all frogs to identify those whose oocytes gave ATP re-
sponses. Responder frogs were placed in a separate tank and reused at in-
tervals of no less than 5 wk. Oocytes from responders continued to dem-
onstrate CFTR-modulated ATP release at a similar frequency and
magnitude during later harvests (up to five harvests have been performed
on responder frogs without a decline in ATP responses).
 
Complementary RNA Synthesis and Injection
into Oocytes
 
Synthesis of complementary RNA (cRNA) from CFTR and mutant cDNAs
was performed using the Megascript cRNA synthesis kit purchased
from Ambion (Austin, TX). Linearized cDNA plasmids were transcribed
at 37
 
8
 
C for 4 h in a reaction mixture supplemented with excess ribonucle-
otide solution that allows an increased rate and duration of cRNA synthe-
sis. RNA cap analogue, m
 
7
 
G(5
 
9
 
)ppp(5
 
9
 
)G (New England Biolabs Inc.,
Beverly, MA) was used to cap and protect the 5
 
9
 
 end of the cRNA. The fi-
nal reaction mixture contained 2Ð4 
 
m
 
g of a linearized cDNA, 1
 
3
 
 tran-
scription buffer provided by the kit, 7.5 mM each of ATP, CTP, and UTP,
1.5 mM of GTP, 6 mM of the cap analogue, and 4 
 
m
 
l of the enzyme mix in
a total volume of 40 
 
m
 
l. 
 
Xenopus 
 
oocytes were injected 24 h after isolation
with 50 nl per oocyte of either DEPC water (mock-injected) or appropri-
ate cRNA (50 ng) using a nanoliter injector (World Precision Instruments,
Inc., Sarasota, FL). Typically, oocytes were analyzed for either ATP re-
sponses or electrophysiologic measurements 48 h after injection.
 
Measurement of the ATP Efflux in Single
Xenopus Oocytes
 
Measurements of the ATP efflux from single oocytes were performed us-
ing a luciferinÐluciferase assay in a TD-20/20 Luminometer (Turner De-
signs, Sunnyvale, CA) under dim light. A single oocyte was rinsed twice in
an appropriate buffer, and was then immersed in 100 
 
m
 
l of the same buffer
containing 3.125 mg/ml luciferinÐluciferase (Sigma Chemical Co.) in a 0.5-ml
Eppendorf tube. Most experiments were done with either Hepes phos-
phate-buffered Ringers (HPBR; 10 mM Hepes, pH, 7.4, 140 mM NaCl, 5
mM KCl, 1.2 mM MgSO
 
4
 
, 1.2 mM CaGluconate, 2.4 mM K
 
2
 
HPO
 
4
 
, and
0.4 mM KH
 
2
 
PO
 
4
 
) or standard oocyte solution (SOS; 5 mM Hepes, pH 7.6,
100 mM NaCl, 2 mM KCl, 1.8 mM CaCl
 
2
 
, and 1 mM MgCl
 
2
 
). When Cl
 
2
 
-
free buffers were used, NaCl was replaced by equivalent amounts of sodium
gluconate. The intracellular Cl
 
2
 
 concentration of oocytes was calculated
from the averaged reversal potentials of CFTR-injected oocytes in the pres-
ence of IBMX (100 
 
m
 
M) and forskolin (10 
 
m
 
M) using the Nernst equation: 
The optimal protocol for eliciting CFTR-modulated ATP release required
the following series of sequential buffer changes that altered the external
Cl
 
2
 
 concentration: (
 
a
 
) Cl
 
2
 
-free; (
 
b
 
) Cl
 
2
 
-free 
 
1 
 
cAMP/forskolin; and (
 
c
 
)
Cl
 
2
 
 (100Ð140 mM) 
 
1 
 
cAMP/forskolin. Luminescence readings were re-
corded by a computer data link for 10 readings of 10 s each in the lumi-
nometer with the sensitivity level set to 89%. When indicated, 8-cpt-
cAMP/forskolin cocktail was added to the experimental buffer to achieve
a final concentration of 200 
 
m
 
M 8-cpt-cAMP and 2.5 
 
m
 
M forskolin. In
some experiments, ionomycin (10 
 
m
 
M; Calbiochem-Novabiochem Corp.,
La Jolla, CA) replaced 8-cpt-cAMP/forskolin in the assay buffer. Buffer
exchange was accomplished by rinsing the oocyte once in the new buffer;
the luminescence assay was then continued for the same amount of time
as described above. Care was taken never to touch the oocyte with pipette
tips. The buffer rinses typically took 
 
z
 
45 s, and account for the absence of
data values during solution switches. To determine the absolute amount
of ATP efflux from an oocyte, standard concentrations of ATP in appro-
priate buffer solutions were measured to establish a calibration curve. In
studies that evaluated the anion dependence of the activation of CFTR-
modulated ATP release, the effects of different anions (gluconate, Cl
 
2
 
,
Ein Eout 58mVlog Cl2 [] in Cl2 [] out ¤ () . – = – 
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Br
 
2
 
, I
 
2
 
,
 
 
 
F
 
2
 
, NO
 
3
 
, and thiocyanate) on the activity of luciferinÐluciferase
were evaluated in preliminary experiments. ATP calibration curves ob-
tained in each buffer revealed that I
 
2
 
,
 
 
 
F
 
2
 
, NO
 
3
 
, and thiocyanate pro-
foundly inhibited luciferinÐluciferase activity. The Cl
 
2
 
 channel blocker
diphenylamine-2-carboxylic acid (DPC) also inhibited luciferinÐluciferase
activity. These reagents were therefore not used in the studies. In contrast,
the ATP activity calibration curves were similar in the presence of gluco-
nate, Cl
 
2
 
, or Br
 
2
 
.
CFTR-modulated ATP release in 
 
Xenopus 
 
oocytes using this luciferinÐ
luciferase assay was successfully reproduced at both the University of
Pennsylvania and Johns Hopkins University.
 
Two-electrode Voltage Clamp Recording
 
Whole-cell (W
 
c
 
) currents were measured using the two-electrode voltage
clamp (TEV) method. Single oocytes were placed in a 1-ml chamber con-
taining modified ND96 (96 mM NaCl, 1 mM KCl, 0.2 mM CaCl
 
2
 
, 5.8 mM
MgCl
 
2
 
, 10 mM Hepes, pH 7.2 by NaOH) connected to a reference bath
electrode by a 3 M KCl-agar bridge (Katayama and Widdicombe, 1991).
Conventional TEV was performed (Sthmer, 1992) at room temperature
using an OC-725C amplifier (Warner Instrument Corp., Hamden, CT)
connected to a PowerMac 7100 via an ITC-16 interface (Instrutech Corp.,
Great Neck, NY). Pulse 
 
1 
 
PulseFit software (HEKA, Port Washington,
NY) was used to ramp the applied transmembrane potential (
 
V
 
m
 
) at 10-s
intervals from 
 
2
 
60 mV to 20 mV at a rate of 16 mV/s. 
 
V
 
m
 
 was clamped at
the prestimulation reversal potential between voltage ramps. Transmem-
brane current (I) and Vm were digitized at 200 Hz during the voltage
ramps, and were written directly onto hard disk. During the course of TEV
recording, the major sources of equipment noise were the 60-Hz spikes in-
duced by the power supply. Therefore, the TEV currentÐapplied voltage
data were fitted with an empirical fifth order polynomial to provide a
smoothed approximation of the TEV data and eliminate the 60-Hz spikes.
The membrane conductance of the oocyte was then calculated as dI/dV
from this approximation. In all TEV experiments performed, a fifth order
polynomial fit very well the observed current-voltage data, which had a
simple monotonically increasing relations within the applied voltage
range. Halide selectivity experiments were performed by replacing NaBr
with NaCl in ND96 solutions. CFTR activation was accomplished by per-
fusing the oocyte with appropriate buffers containing 100 mM IBMX and 10
mM forskolin (Sigma Chemical Co.). In all experiments, CFTR Cl2 con-
ductance was defined as the difference in conductance measured in the
presence and in the absence of 100 mM IBMX and 10 mM forskolin. The
cAMP-stimulated Cl2 and Br2 conductances of the R347E mutant (5.3 6
2.1 ms and 12.15 6 3.3 ms, respectively) were much lower than that of the
wild type. In control experiments, the conductance changes of mock-injected
oocytes in response to IBMX/forskolin treatment were Ð0.61 6 0.62 ms in
the presence of Cl2 and 0.11 6 0.39 ms in the presence of Br2. These back-
ground non-CFTR conductance changes were subtracted from the mea-
sured changes of CFTR and mutants. In the case of mutant R347E, this
correction caused only a small change in the calculated GBr/GCl value
from 2.60 (without background correction) to 2.36 (with background cor-
rection). The Wc conductance (at 220 mV) and reversal potential (Erev)
after agonist stimulation of CFTR channels (wild type or mutants) were
evaluated from the slope and x intercept, respectively, of the background-
corrected IÐVm curve using Igor Pro software (WaveMetrics, Lake Os-
wego, OR). After each buffer perfusion (1 min), conductance was mea-
sured over 10 min to ensure equilibrium was reached. GBr/GCl is the ratio
of the Wc conductances of stimulated CFTR channels in Br2 vs. Cl2 solu-
tion. The permeability ratio (PBr/PCl) was calculated from the reversal po-
tentials Erev,Br and Erev,Cl in Br2 and Cl2 solutions, respectively, using
which is based on the GoldmanÐHodgkinÐKatz equation, with [Br2] and
[Cl2] being the concentrations of Br- and Cl- in the solutions, and R, T,
and F having their conventional meanings.
Preparation of CFTR Mutants
Five CFTR mutants were analyzed for their ability to modulate ATP re-
lease using the luciferinÐluciferase assay as well as their capacity to con-
duct Cl2 and Br2 using voltage clamping. For mutant R347, a cDNA seg-
ment was cut out from the PTM1-R347E CFTR construct (kindly
provided by Dr. M. Welsh, University of Iowa) by restriction enzymes
Erev,Br Erev,Cl
RT
F
-------
PBr Br
2 []
PCl Cl
2 []
--------------------------
èø
ç÷
æö
ln = –
MroI and Bst1107I, and was subcloned into the pBQ-CFTR plasmid be-
tween the same restriction sites. Mutants R334W and R347P were con-
structed by replacing a SpH IÐXba I segment in the PSP-CFTR with a cor-
responding segment cut out from mutants PTM-R334W and PTM-R347P
(provided by Dr. M.J. Welsh; Sheppard et al., 1993), respectively. Success-
ful transfer of the mutated sequences was confirmed by sequencing. The
COOH-terminal truncation mutant, TMD1 CFTR, was constructed by in-
troducing a stop codon at K370X followed by an EcoRV restriction site
using the mutagenic oligonucleotide 59-GCAATAAACTAAATACAG-
GATATCTTAC-39. The NH2-terminal truncation mutant D259-M265V
CFTR was constructed as previously described (Piazza Carroll  et al.,
1995).
Immunoprecipitation of CFTR and Mutants from 
cRNA-injected Xenopus Oocytes
Synthesis of 35S-labeled wild-type and mutant CFTR proteins in Xenopus
oocytes was achieved by coinjection of appropriate cRNAs with [35S]me-
thionine. The injection mixtures were made by adding 50 mCi of 35S-methi-
onine (ICN) to 2.0 ml of transcripts. Each oocyte was injected with 50 nl
of a mixture containing 50 ng of cRNA and 0.5 mCi 35S. After incubating
for 3 h at 188C in MBS, oocytes were collected, quickly frozen on dry ice,
and stored at 2808C until use. For immunoprecipitation, oocytes in
groups of five were thawed and homogenized on ice in 30 ml of 50 mM
Tris (pH 7.5), 0.25 M sucrose, 50 mM KCl, 5 mM MgCl2, and 1 mM DTT
followed by solubilization with 100 ml of 1% SDS and 0.1 M Tris (pH 8.0).
Samples were incubated for 30 min at 378C, diluted in 1 ml of TX SWB
buffer (0.1 M NaCl, 1% Triton X-100, 2 mM EDTA, 0.1 mM PMSF and
0.1 M Tris, pH 8.0) on ice, and further incubated at 48C for 2 h. Before im-
munoprecipitation, samples were centrifuged at 16,000 g for 15 min, and
supernatants were collected. Immunoprecipitation of CFTR was initiated
by adding 1 ml of an epitope-specific rabbit antisera raised against a syn-
thetic peptide corresponding to residues 45Ð56 in the CFTR NH2 terminus
and mixing at 48C for 1.5 h. 5 ml of Affigel protein A (Bio-Rad Laborato-
ries, Hercules, CA) was added, and the reaction mixture was further incu-
bated at 48C for another 1.5 h. After washing five times in TX SWB, pro-
tein A beads were pelleted by brief centrifugation in a microcentrifuge
and resuspended in 1X sample loading buffer. Samples were denatured at
378C for 30 min and analyzed on 7.5% SDS PAGE. After electrophoresis,
gels were fixed in 35% methanol and 10% HAc, dried, and exposed to
film for autoradiography.
Results
ATP Release from CFTR-expressing Xenopus Oocytes
ATP release from Xenopus oocytes was studied using a
single oocyte luciferinÐluciferase luminometric assay. Ini-
tial experiments compared water and CFTR cRNAÐ
injected oocytes under conditions that promote Cl2 flux
through CFTR. In the presence of Cl2-free Ringers con-
taining 200 mM 8-(4-chlorophenylthio)-adenosine 39:59-
cyclicmonophosphate (8-cpt-cAMP)/2.5 mM forskolin, no
activation of ATP efflux was observed for up to 10 min
(Fig. 1 and data not shown). Similarly, no ATP efflux was
observed when either CFTR- or water-injected oocytes
were incubated in the presence of high (140 mM) extracel-
lular Cl2 and cAMP/forskolin for 10 min (data not shown).
However, prestimulation of oocytes with cAMP/forskolin
in Cl2-free Ringers, followed by an acute exposure to 140
mM Cl2 Ringers, was associated with a significant and im-
mediate ATP efflux in a subset (z50%, N 5 41) of CFTR-
injected oocytes (Fig. 1, A and B). Activation of ATP ef-
flux in oocytes was dependent on CFTR expression, and
was never observed in water-injected oocytes (N 5 41).
CFTR activation was required to elicit ATP efflux since it
was not seen when similar protocols were carried out in
the absence of cAMP agonists (data not shown). The la-
tency as well as the initial rate of ATP efflux during theThe Journal of Cell Biology, Volume 143, 1998 648
first 45 s could not be assessed because of the time re-
quired for buffer washes. However, steady-state rates of
ATP efflux were quantitated by calculating the slope of
relative light units vs. time for each individual oocyte, and
correlating the per minute light unit change with standards
of known ATP concentration. In a select number of exper-
iments, steady-state rates of ATP efflux in CFTR-injected
oocytes remained constant for periods extending up to 3
min, which was the longest time course analyzed. How-
ever, in CFTR-injected oocytes that gave very high levels
of ATP efflux, slight time-dependent declines in the
steady-state rates could be seen, and may represent tran-
sient depletions of available intracellular ATP pools. The
cumulative data depicted in Fig. 1 C demonstrate a mean
ATP efflux rate of 1.99 6 0.55 pmoles ATP/min (N 5 41)
for CFTR cRNA-injected oocytes, compared with 20.005 6
0.004 pmoles ATP/min (N 5 41) for water-injected oo-
cytes. The various treatment conditions and their effects
on CFTR-modulated ATP release are summarized in Ta-
ble I.
Because these studies used mammalian Ringer solu-
tions, additional experiments were performed to compare
responses directly using SOS. In these studies, the ATP ef-
flux rate (2.0 6 1.1 pmoles ATP/min) in SOS buffer (100 mM
NaCl) was threefold lower than that seen in the mamma-
lian buffer (140 mM NaCl; 6.3 6 2.2 pmoles ATP/min).
However, activation of CFTR-modulated ATP release
was still dependent on cAMP activation and the switch
from low to high extracellular Cl2. These findings suggest
that buffer osmolarity does not significantly alter the pro-
file of CFTR-modulated ATP release. There were no sig-
nificant changes in buffer osmolarity after anion replace-
ment for either the HPBR or the SOS buffer series (Table
II). Therefore, it is unlikely that the pattern of ATP re-
lease seen after changes in extracellular chloride is due to
osmolarity changes in assay buffers. As addressed later,
the lower ATP efflux rates seen in SOS are likely due to
the dependence of CFTR-modulated ATP release on ex-
tracellular Cl2 concentrations.
ATP Release Cannot be Explained by CFTR-facilitated 
Changes in Membrane Potential or Cell Volume
Not all CFTR cRNA-injected oocytes that expressed
CFTR, as demonstrated by high whole cell (Wc) cAMP-
activated Cl2 conductances, released ATP after a shift
from low to high Cl2 extracellular medium in the presence
of cAMP agonists (Fig. 1 D). Thus, CFTR expression was
necessary, but not sufficient, to confer the ATP permeabil-
ity. Nevertheless, we considered that elevation of extracel-
lular Cl2 might hyperpolarize the cell membrane and drive
ATP anions from the cell through unspecified pathways.
Figure 1. LuciferinÐluciferase
detection of CFTR-modulated
ATP release in cRNA-injected
Xenopus oocytes. Isolated Xe-
nopus  oocytes were injected 24 h
after harvest with either 50 ng of
CFTR cRNA or an equivalent
volume of water, and allowed to
incubate at 158C for 2 d. Single
oocytes were then assessed for
ATP efflux after serial incuba-
tion in: (1) 140 mM Na-gluconate/
HPBR; (2) 140 mM Na-gluco-
nate/HPBR, 200 mM 8-cpt-cAMP,
2.5  mM forskolin; and (3) 140
mM NaCl/HPBR, 200 mM 8-cpt-
cAMP, 2.5 mM forskolin. All
buffers contained 3.125 mg/ml luciferinÐluciferase. A depicts the kinetics of ATP ef-
flux as the mean raw relative light units (6 SEM) vs. time for all oocytes (N 5 41) ana-
lyzed from five independent responder frogs. Arrows denote the time of buffer washes
with a duration of z45 s. The rates of ATP efflux during each buffer condition
(pmoles/min) were calculated for individual oocytes from the slope of relative light
units vs. time (for the 100-s reading) using ATP concentration curve standards (1
pmole ATP equaled 90 light units at the sensitivity used in this study). B depicts the
raw individual rates of ATP efflux for all oocytes analyzed in each treatment group
(N 5 41). These cumulative results demonstrate an average of 50% responsiveness in
CFTR cRNA-injected and 0% in water-injected oocytes for ATP efflux after elevating extracellular Cl2 in the presence of cAMP ago-
nists. The mean rates (6 SEM) of ATP efflux for each set of oocytes in B are shown in the inset (C). All experiments represent cumula-
tive data from five independent frogs for which equal numbers of water- and CFTR cRNA-injected oocytes were assessed for ATP ef-
flux within each batch of oocytes. All oocytes analyzed were included in these results. D correlates the magnitude of CFTR-modulated
ATP release and forskolin/IBMX-inducible Cl2 conductances in oocytes from two independent frogs. These studies were performed by
sequentially measuring ATP efflux followed by Wc conductance on the same CFTR cRNA-injected oocyte. ATP efflux experiments
were performed as in A, and rates indicated are in the presence of buffer 3 (140 mM NaCl/cAMP/Forskolin). Solid points represent oo-
cytes that gave positive ATP efflux rates, while open boxes are oocytes with no ATP efflux. The dashed line depicts the correlation (r 5
0.74) in the magnitude of ATP efflux rates in those oocytes that secreted ATP, with cAMP-inducible Cl2 conductances from the same
oocytes.Jiang et al. CFTR Controls ATP Release in Xenopus Oocytes 649
To determine whether changes in membrane potential
during the experimental protocol contributed to the
CFTR-associated ATP effluxes, we evaluated the effects
of stimulating CFTR-independent Cl2 channels in our
ATP release assay. Ionomycin (10 mM), which activates
endogenous Cl2 channels in oocytes by releasing Ca21
from intracellular stores (Yoshida and Plant, 1992; Liu and
Harmann, 1978; Boton et al., 1990), failed to evoke ATP
efflux from mock-injected oocytes (Fig. 2, A and B). In
contrast, CFTR-injected oocytes from the same batches of
oocytes demonstrated substantial ATP effluxes in re-
sponse to CFTR activation (Fig. 2, A and B). The lack of
ATP efflux in ionomycin-treated oocytes was not due to
inhibitory effects of ionomycin on luciferinÐluciferase ac-
tivity, as determined by performing the standard ATP con-
centration calibration in the presence of ionomycin (Fig. 2
C). Treatment of uninjected oocytes with 10 mM ionomy-
cin elicited Cl2 conductances (104 6 28 ms) of comparable
magnitude to those in CFTR cRNA-injected oocytes (121 6
35 ms) stimulated with IBMX/forskolin. Preincubation of
oocytes for 5 min in a Cl2-free solution before TEV did
not significantly lower the intracellular Cl2 concentration
(42.54 6 1.65 mM), as assessed by reversal potential deter-
mination. These data therefore demonstrate that activa-
tion of a Cl2 permeability per se is incapable of stimulat-
ing the ATP efflux, and suggest that the efflux observed
during activation of CFTR cannot be accounted for by
changes in electrical driving forces.
Although osmolarity was held constant in the protocols,
we evaluated the potential involvement of cell volume
perturbations that might arise from Cl2 fluxes during the
changes in extracellular Cl2 concentration. The volumes
of oocytes injected with CFTR cRNA were assessed with
digital imaging as previously described (Takahashi et al.,
1996; Jentsch, 1996). Batches of CFTR cRNAÐinjected oo-
cytes that demonstrated CFTR-modulated ATP release
exhibited undetectable changes (,2%) in cell volume (9.0 3
1024 6 0.11 3 1024 cm3) after exposure to the series of so-
lutions used to activate CFTR-modulated ATP release.
The data suggest that substantial changes in oocyte vol-
ume do not account for the observed ATP efflux.
Dissociation of Cl2 Conductance and ATP Efflux 
Functions Associated with CFTR
Because the results indicated that CFTR was necessary
but not sufficient for ATP permeability, we attempted to
identify the important domains in CFTR by comparing
wild-type CFTR with two deletion mutants, TMD1 and
D259-M265V. The TMD1 mutant encompassing the NH2-
terminal portion of CFTR encoded the first 369 amino ac-
ids (first six transmembrane helices), while in the D259-
M265V mutant the first 259 amino acids were deleted and
the methionine 265 was mutated to a valine. Oocytes ex-
pressing the TMD1 CFTR mutant generated z30% of the
wild-type CFTR Cl2 conductance. However, ATP efflux
was not associated with this mutant (Fig. 3). In contrast,
expression of the D259-M265V mutant was associated with
near wild-type rates of ATP efflux in the absence of de-
tectable Cl2 conductances (Fig. 3). These results demon-
strate that the ability of the CFTR to modulate ATP re-
lease can be dissociated from its Cl2 conducting activity.
Activation of CFTR-modulated ATP Release 
Demonstrates Selectivity for Extracellular Halides
In addition to Cl2, CFTR is permeable to other halides
and small anions, including Br2, I2, F2, and NO3
2 (Ander-
son et al., 1991; Tabcharani et al., 1993). Because changing
the extracellular Cl2 concentration appeared to be critical
for activating CFTR-modulated ATP release in oocytes,
we explored the anion dependence of this activation. As
indicated in Materials and Methods, all anions tested, with
the exception of Br2 and Cl2, significantly inhibited the
luciferinÐluciferase reaction (Fig. 4 B). The anion depen-
dence experiments were therefore limited to Cl2 and Br2.
Replacement of 140 mM extracellular Cl2 with 140 mM
Br2 caused a fourfold decrease in the rate of CFTR-
dependent ATP release (Fig. 4 A), which was reversed
when Br2 was replaced with Cl2 (Fig. 4 A). This halide
specificity was also seen in SOS buffers. No effect of
changing the extracellular halide was observed in water-
injected oocytes (data not shown). Although the magni-
tude of CFTR-modulated ATP release was threefold
lower in the presence of 100 mM Cl2 when compared with
140 mM Cl2, the Cl2:Br2 halide dependence of ATP re-
lease was significantly greater in SOS buffers (Fig. 4 C).
The sensitivity of CFTR-modulated ATP release to the
external Cl2 concentration and the apparent halide selec-
tivity of this phenomenon suggested that a Cl2 sensor may
exist within CFTR that responds to Cl2 concentration
Table I. Buffer Conditions and Their Effects on ATP Efflux
Buffer sequence
ATP
release
140 mM Na-gluconate No
140 mM Na-gluconate, 140 mM Na-gluconate 1 cAMP/Forsk No
140 mM NaCl No
140 mM NaCl, 140 mM NaCl 1 cAMP/Forsk No
140 mM Na-gluconate, 140 mM NaCl No
140 mM Na-gluconate, 140 mM Na-gluconate 1 cAMP/Forsk, 
140 mM NaCl 1 cAMP/Forsk Yes
140 mM Na-gluconate, 140 mM Na-gluconate 1 cAMP/Forsk,
140 mM NaCl Yes
140 mM NaCl, 140 mM NaCl 1 cAMP/Forsk, 140 mM 
Na-gluconate 1 cAMP/Forsk No
Buffer sequences analyzed for CFTR modulated ATP release are represented in order.
Various lengths of exposure ranged from 2Ð10 min as described in Results. Buffer
conditions are based on an HPBR solution as described in Materials and Methods.
ATP release was indicated as any observable increase in the overall magnitude of rel-
ative fluorescence.
Table II. Osmolarity of Buffers Used in ATP Efflux Assay
Buffer base Predominant anion composition Osmolarity
mOsmol
HPBR 140 mM NaCl 303 6 5
140 mM Na-gluconate 295 6 3
140 mM NaBr 293 6 4
SOS 100 mM NaCl 205 6 2
100 mM Na-gluconate 204 6 2
100 mM NaBr 204 6 3
The osmolarity of these solutions was determined on a Multi-Osmette Model 2430
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changes in the external environment by activating ATP ef-
flux. To test this hypothesis, we examined the dependence
of ATP release on the concentration of extracellular Cl2
in CFTR cRNAÐinjected oocytes.
Dependence of CFTR-modulated ATP on the External 
Cl2 Concentration
The effect of extracellular Cl2 on the rate of ATP efflux in
CFTR-expressing oocytes was determined by increasing in
a step-wise fashion the extracellular concentration of Cl2
from 0 to 140 mM in the presence of cAMP/forskolin. Os-
molarity was kept constant throughout the experiments by
gluconate replacement. The cumulative results from two
independent batches of oocytes demonstrated a sharp
threshold for activation of CFTR-modulated ATP release
at extracellular concentrations of Cl2 .100 mM (Fig. 5 A).
Results from two additional batches of oocytes narrowed
the range of Cl2 necessary for activation of ATP release.
The cumulative results from four frogs demonstrated that
ATP efflux rates were dramatically increased between 110
and 120 mM extracellular Cl2 (Fig. 5 B). In these studies,
Figure 2. Absence of ATP ef-
flux after activation of Ca1-acti-
vated Cl2 conductance in oo-
cytes. To assess whether
membrane potential changes
due to opening of Cl2 channels
in oocytes could nonspecifically
facilitate ATP efflux, the rates
of ATP efflux in cAMP/forsko-
lin stimulated CFTR cRNA-
injected oocytes, and ionomycin-
treated water-injected oocytes
were compared. A demonstrates
the mean (6 SEM) relative light
units produced from oocytes de-
rived from two frogs after expo-
sure to the following sequence of buffers: (1) 140 mM Na-gluconate/HPBR; (2) 140 mM Na-gluconate/HPBR 1 (200 mM 8-cpt-cAMP,
2.5 mM forskolin, or 10 mM ionomycin); and (3) 140 mM NaCl/HPBR 1 (200 mM 8-cpt-cAMP, 2.5 mM forskolin, or 10 mM ionomycin).
Buffer changes are denoted by arrows, and the treatment conditions are indicated in the legend. B depicts the mean (6 SEM) rate of
ATP efflux for each buffer condition as calculated from the slope of relative light units vs. time (for the 100-s reading) for each individ-
ual oocyte. ATP concentration curve standards were used to calibrate rates in terms of pmoles/min (1 pmole ATP 5 90 light units). All
oocytes analyzed were included in these results. To demonstrate that ionomycin has no effect on the activity of luciferinÐluciferase, we
compared standard curves for ATP in the presence of buffers and agonists used for the above study (C). Ionomycin standard curves
were measured in Na-gluconate buffers.
Figure 3. Comparison of CFTR-
modulated ATP release be-
tween wild-type, TMD1, and
D259-M265V CFTR cRNAÐ
injected  Xenopus  oocytes. Results
in A demonstrate the mean (6
SEM) relative light units pro-
duced by CFTR cRNAÐinjected
oocytes exposed to the following
order of buffers: (1) 140 mM Na-
gluconate/HPBR; (2) 140 mM
Na-gluconate/HPBR, 200 mM
8-cpt-cAMP, 2.5 mM forskolin;
and (3) 140 mM NaCl/HPBR, 200
mM 8-cpt-cAMP, 2.5 mM forsko-
lin. Buffer changes are denoted
by arrows, and cRNA injected is
indicated in the legend. B de-
picts the mean (6 SEM) rate of
ATP efflux for each buffer con-
dition as calculated from the
slope of relative light units vs.
time (for the 100-s reading) for each individual oocyte. C depicts the mean (6 SEM) Wc chloride conductance values representing the
total and delta conductance after adding forskolin/IBMX to the bathing solution (corrected for water-injected background). D gives the
mean I/V relationships for each construct in the presence and absence of the cAMP agonists forskolin/IBMX. An equal number (N) of
wt CFTR, TMD1, and D259-M265V cRNA-injected oocytes were assessed for ATP efflux within each of two batches of oocytes. All oo-
cytes analyzed were included in these results derived from two independent frogs.Jiang et al. CFTR Controls ATP Release in Xenopus Oocytes 651
maximum levels of ATP efflux were fivefold greater in the
presence of extracellular Cl2 when compared with Br2. In-
terestingly, when the external Cl2 concentration was de-
creased step-wise after a strong ATP response was in-
duced with 140 mM NaCl, the rate of ATP efflux remained
elevated at maximum levels at external Cl2 concentrations
.100 mM, and only returned to baseline once more signif-
icant reductions in extracellular Cl2 ( ,80 mM) were
imposed (data not shown). These results suggest that
CFTR-modulated ATP release may have differential re-
quirements for extracellular Cl2 depending on the direc-
tion of the gradient change and/or the state of prior activa-
tion. Together, these findings suggest that a chloride
sensor within CFTR may be capable of regulating ATP ef-
flux near physiologic concentrations (85Ð130 mM) of Cl2
seen in the airway (Joris et al., 1993; Gilljam et al., 1989;
Smith et al., 1996).
Mutations in the CFTR Channel Pore Alter the Halide 
Dependence of ATP Release
To explore the mechanisms by which changes in the extra-
cellular Cl2 concentration affect activation of ATP re-
lease, we examined the CFTR mutants R334W, R347P,
and R347E. We hypothesized that positively charged resi-
dues within the channel pore might bind Cl2 and elicit
structural changes in CFTR necessary for modulating
ATP release. Immunoprecipitation studies using a rabbit
antisera raised against a synthetic peptide corresponding
to residues 45Ð65 in the CFTR NH2 terminus demon-
strated similar levels of protein expression in wtCFTR,
R334W, R347P, and R347E cRNAÐinjected oocytes (Fig.
6 A). No CFTR protein was detected in water-injected oo-
cytes.
The electrophysiologic properties of wtCFTR and each
of the mutants were analyzed in cRNA-injected oocytes
by two-electrode voltage clamp. WtCFTR-injected oo-
cytes demonstrated a large increase in slope conductance
(DGcAMP 5 121 6 35 ms) in response to 10 mM forskolin
and 100 mM IBMX (Fig. 6 and Table II). Of note, the con-
ditions used in the ATP efflux experiments (200 mM 8-cpt-
cAMP/2.5 mM forskolin) produced approximately tenfold
lower conductance changes (data not shown). No cAMP-
activated currents were seen in water-injected oocytes un-
der either condition. We therefore used maximum levels
of stimulation to facilitate detection of subtle changes in
halide selectivities of low-conducting mutants. The stimu-
lated Cl2 conductance of R347P was comparable to that of
the wtCFTR (DGcAMP 5 125 6 28 ms). In contrast, the
stimulated Cl2 conductances were 4- and 20-fold lower in
the R334W and R347E mutants, respectively (Fig. 6 and
Table II). The I/V relationships for unstimulated and
cAMP-stimulated oocytes in the presence of Cl2 and Br2
are shown in Fig. 6 and summarized in Table II. The mu-
tants R347P and R334W demonstrated slight alterations in
their conductance ratios (GBr/GCl; Br2 . Cl2) as com-
pared with wtCFTR (Cl ù Br). In contrast, both GBr/GCl
and PBr/PCl were significantly altered by the R347E muta-
tion (Table II). These data support previous findings that
arginine 347 is important in determining the halide selec-
tivity of the CFTR channel pore (Tabcharani et al., 1993;
Anderson et al., 1991).
Rates of CFTR-modulated ATP release for the mutant
CFTRs are summarized in Fig. 7. These studies were de-
signed to enable comparison of ATP efflux rates in re-
sponse to extracellular changes in Cl2 and Br2 within a
single oocyte. Frogs that had previously demonstrated
CFTR-modulated ATP release in .25% of oocytes were
used. As previously demonstrated, exposure of wtCFTR-
Figure 4. CFTR-modulated ATP release is influenced by extra-
cellular halides. A depicts the mean (6 SEM) relative light units pro-
duced by CFTR cRNA-injected oocytes (N 5 25) from five frogs.
Oocytes were exposed to the following order of buffers: (1) 140 mM
Na-gluconate/HPBR; (2) 140 mM Na-gluconate/HPBR, 200 mM
8-cpt-cAMP, 2.5 mM forskolin; (3) 140 mM NaCl/HPBR, 200
mM 8-cpt-cAMP, 2.5 mM forskolin; (4) 140 mM NaBr/HPBR, 200
mM 8-cpt-cAMP, 2.5 mM forskolin; and (5) 140 mM NaCl/HPBR,
200 mM 8-cpt-cAMP, 2.5 mM forskolin. Buffer changes are de-
noted by arrows. Only oocytes that demonstrated release in the
presence of extracellular Cl2 (arrow 3) were pooled for this anal-
ysis. The mean (6 SEM) rates of ATP efflux calculated from the
rates for each individual oocyte were 3.3 6 1.5 pmoles ATP/min
(buffer 3), 1.0 6 0.5 pmoles ATP/min (buffer 4), and 4.0 6 1.7
pmoles ATP/min (buffer 5). B depicts the affects of various ha-
lides and anions on the activity of luciferinÐluciferase using stan-
dard curves for ATP (no differences were seen in Cl and Br-con-
taining buffers). The halide selectivity of CFTR-modulated ATP
release in SOS and HPBR was compared in C. These studies
evaluated ATP efflux in wtCFTR cRNA-injected oocytes using
the specified order of buffers as shown in the figure (details of
buffer composition are described in Materials and Methods). Re-
sults depict the mean (6 SEM, N 5 6) relative light units pro-
duced in each buffer with mean (6 SEM) rates of ATP efflux
shown above each line. Calculated rates of ATP efflux are the
mean of rates from individual oocytes in pmoles ATP/min. In this
analysis, oocytes that demonstrated no ATP efflux under all of
the buffer conditions were not included in these calculations that
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expressing oocytes to Cl2-free buffers was necessary for
activation of ATP efflux following a concentration change
to high extracellular Cl2 (JATP 5 8.7 6 3.4 pmoles/min).
This represents a greater than 400-fold increase in ATP ef-
flux when compared with side-by-side controls in water-
injected control oocytes (JATP 5  0.021  6 0.001 pmoles/
min). The typical ATP response curves obtained for
wtCFTR demonstrated a halide dependence of Cl2 ..
Br2. In the presence of extracellular Br2, JATP was approx-
imately fourfold lower (1.9 6 0.5 pmoles/min) compared
with the rate in the presence of Cl2. Again, this inhibition
was reversed by replacing extracellular Cl2 (Fig. 7 A).
The halide dependence of CFTR-modulated ATP re-
lease was similarly analyzed in R334W, R347P, and R347E
cRNA-injected oocytes. WtCFTR cRNA-injected oocytes
were also examined at the same time to assure the respon-
siveness of the oocytes. The halide dependence of ATP
release for R347P CFTR was similar to that of wtCFTR
(Cl2 .. Br2); JATP in the presence of Cl2 (2.0 6 0.98
pmoles/min) was eightfold greater than that in the pres-
ence of Br2 (0.26 6 0.17 pmoles/min; Fig. 7 and Table II).
These results correlate with the similar anion conductance
and permeability characteristics of this mutant and
wtCFTR. In contrast, the R334W mutant had no halide de-
pendence in the activation of ATP release (JATP[Cl] 5 3.4 6
1.3 pmoles/min, JATP [Br] 5 3.7 6 1.5 pmoles/min; Fig. 7).
Most importantly, the halide dependence in the R347E
mutant was reversed to Br2 .. Cl2; JATP in the presence
of Cl2 (1.5 6 0.49 pmoles/min) was 7.3-fold lower than
that in the presence of Br2 (11 6 4.8 pmoles/min; Fig. 7
and Table II). Interestingly, exposure of R347E-express-
ing oocytes to extracellular Br2 had a lasting affect on
JATP, even after extracellular Br2 was replaced with Cl2. In
summary, these results suggest that residues R334 and
R347 may participate in the extracellular halide depen-
dence of CFTR-modulated ATP release. We hypothesize
that these positively charged residues which have been
suggested to contribute to the Cl2 selectivity of the CFTR
pore may also contribute to a chloride sensor at which Cl2
binding facilitates structural changes in CFTR necessary
to modulate ATP release.
Discussion
The results from this study indicate that CFTR can modu-
late ATP release in Xenopus oocytes, provided that sev-
eral requirements are met. First, activation of ATP release
requires CFTR expression. Second, CFTR must be acti-
vated by cAMP. Finally, CFTR-modulated ATP release
was dependent on an incremental increase in the extracel-
lular Cl2 concentration. These findings suggest a novel
Cl2-dependent mechanism by which CFTR regulates ATP
release. The complexities associated with activation of this
CFTR-mediated phenomenon may in part explain the
present controversies concerning CFTR-modulated ATP
release.
Possible Mechanisms of CFTR-modulated ATP Release
We evaluated the possibility that activation of Cl2 con-
ductance per se, combined with a change of extracellular
Cl2 concentration, could account for ATP release as a
consequence of hyperpolarizing the membrane potential.
However, the absence of ATP release in response to iono-
mycin, which activated a non-CFTR endogenous Ca21-
activated Cl2 conductance, ruled out such a mechanism.
We also considered a second mechanism involving pertur-
bations of cell volume. In mammalian cells it has been re-
ported that the release of intracellular ATP can be ob-
served under conditions that cause cell swelling (Greger et
al., 1993, Koslowsky et al., 1994). However, direct mea-
surements failed to reveal any alteration of cell volume in
oocytes that demonstrated CFTR-modulated ATP re-
lease. Furthermore, for changes in cell volume to occur in
Figure 5. Extracellular Cl2 con-
centration determines the rela-
tive activity of CFTR-modulated
ATP release. Two independent
batches of wtCFTR cRNA-
injected  Xenopus  oocytes were
analyzed for the effects of extra-
cellular Cl2 concentration on
the activation of ATP efflux. An
HPBR solution was used
throughout these experiments
with alterations in the final NaCl
concentration facilitated by ex-
change of an equal molar
amount of Na-gluconate with
NaCl. The total concentration of NaCl and Na-gluconate was equal to 140 mM throughout these experiments with a constant osmolar-
ity. A demonstrates the mean (6 SEM) relative light units produced by CFTR-expressing oocytes for which the extracellular Cl2 con-
centration was incrementally increased by adding NaCl-containing buffers with a constant concentration of luciferinÐluciferase en-
zymes. Between seven and eleven oocytes were evaluated at each Cl2 concentration from two independent frogs. At the end of the
experiment, Cl2 was replaced with Br2 to confirm the halide selectivity of the oocytes analyzed. Oocytes that did not demonstrate ATP
efflux above water-injected controls (data not shown) were not included in this data set. B depicts the mean (6 SEM) rates of ATP ef-
flux from cumulative data of four independent batches of CFTR cRNA-injected oocytes as a function of Cl2 concentration. The rate of
ATP efflux in the presence of extracellular Br2 is also included for reference. The concentration of extracellular Cl2 necessary for acti-
vation of CFTR-modulated ATP efflux was z115 mM (arrow).Jiang et al. CFTR Controls ATP Release in Xenopus Oocytes 653
CFTR cRNA but not water-injected oocytes, one would
anticipate that Cl2 flux through CFTR would be required
for movement of NaCl and water into oocytes. However,
the CFTR mutant D259-M265V, which failed to conduct
Cl2, also conferred near wild-type rates of ATP release. In
summary, the lack of correlation between CFTR-modu-
lated ATP release with the magnitude of anion conduc-
tance suggests that salt and water movement and changes
in cell volume are likely not involved in activating ATP re-
lease in this system.
Several lines of evidence suggest that ATP and Cl2 per-
meation occur through distinct pathways in CFTR-
expressing oocytes. First, the CFTR mutant D259-M265V
demonstrated near wild-type rates of CFTR-modulated
ATP release despite its inability to conduct Cl2. In con-
trast, TMD1 mutants gave appreciable Cl2 conductances
in the absence of activatible ATP release. Furthermore,
the R347E had a greater than 20-fold reduced GBr as com-
pared with wtCFTR, yet the magnitude of JATP in the pres-
ence of extracellular Br2 was sixfold higher for R347E
when compared with wtCFTR cRNA-injected oocytes.
Taken together, these data demonstrate that the perme-
ation pathway associated with CFTR-modulated ATP re-
lease is independent of the Cl2 conductance pathway in
the channel pore. The observations that only a subset of
CFTR-expressing oocytes displayed an ATP permeability
despite equivalent levels of cAMP inducible Cl2 conduc-
tances also supports this conclusion. Of note, however,
frogs that produced ATP responder oocytes continued to
produce oocytes with CFTR-modulated ATP release in
subsequent harvests (see Materials and Methods for more
detail). We therefore hypothesize that another factor(s) is
required in addition to activated CFTR to confer ATP re-
lease in Xenopus oocytes. This conclusion is similar to that
reached in MDCK cells, where CFTR-dependent ATP
conductances were seen at the single channel level in 30%
of patches containing active CFTR Cl2 currents (Sugita
et al., 1998). Despite the possible need of a cofactor, the
rate of CFTR-modulated ATP release correlated (r 5
0.74) with the magnitude of the Cl2 conductance as mea-
sured sequentially in the same oocyte (Fig. 1 D). These
data suggest that both the abundance of CFTR and some
other factor(s) likely affect the overall magnitude of ATP
efflux.
CFTR-mediated ATP Release Depends on Changes in 
Extracellular Chloride Concentration
Unique to the present study evaluating CFTR-mediated
ATP release is the dependence of activation on changes in
the extracellular Cl2 concentration. Chloride-dependent
activation of CFTR-modulated ATP release occurred
within a very narrow range of Cl2 concentrations (110Ð120
mM), although the range of chloride concentrations neces-
sary to sustain maximal levels of ATP efflux was slightly
broader (85Ð140 mM) once CFTR-modulated ATP re-
lease was activated. We hypothesize that the interaction of
Cl2 with basic residues within extracellular domains or the
channel pore may mediate structural changes in CFTR
necessary to activate ATP release. To explore this idea,
we examined the halide dependence of ATP release and
compared it to the halide conductance properties of CFTR
channels. The halide dependence experiments were lim-
ited to Cl2 and Br2, since other anions, including I2, F2,
NO3
2, and SCN2, significantly inhibited luciferinÐluciferase
activity. Our studies of Wc conductance and permeability
of wtCFTR in the presence of external Cl2 and Br2 were
similar to previous findings (GCl >  GBr and PBr . PCl;
Anderson et al., 1991). Interestingly, these ratios (GBr/GCl 5
0.93 6 0.01, PBr/PCl 5 1.13 6 0.02) were significantly larger
than the ratio of halide dependence of CFTR-modulated
ATP efflux (JATP[Cl] 5 8.7 6 3.4 pmoles ATP/min,
JATP[Br] 5 1.9 6 0.52 pmoles ATP/min). Thus, the activa-
tion of CFTR-modulated ATP release appears to have a
higher specificity for Cl2 when compared with the perme-
Figure 6. Electrophysiological properties of CFTR mutants using
Wc two-electrode voltage clamp measurements. Mutants of
CFTR that alter charged arginine residues within the channel
pore including R334W, R347E, and R347P were used. A demon-
strates the amount of [35S]methionine-labeled CFTR immuno-
precipitated with anti-hCFTR antibodies from oocytes injected
with mutant and wild-type CFTR cRNAs. The arrow depicts un-
glycosylated CFTR protein produced 3 h after injection. The Wc
I/V relationships for wtCFTR, R347P, R347E, R334W cRNA,
and water-injected oocytes are given in B. Arrows denote the I/V
relations before forskolin/IBMX activation in the presence of ex-
tracellular Cl2 (marked baseline) and after adding forskolin/
IBMX in the presence of extracellular Cl2 (Cl) and bromide (Br).
Stimulation of CFTR was performed by perfusion of the oocyte
with appropriate buffers containing 100 mM IBMX and 10 mM
forskolin. ND96 buffer was used throughout the experiment
where NaBr replaced NaCl for halide selectivity measurements.
The order of buffer perfusion was as follows: (a) ND96 (NaCl);
(b) ND96 (NaCl) 1 forskolin/IBMX; and (c) ND96 (NaBr) 1
forskolin/IBMX. These results depict average I/V relationships
from N experiments for wtCFTR (N 5 5), R347E (N 5 5), R347P
(N 5 5), R334W (N 5 8), and water (N 5 7)-injected oocytes
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ability properties of the CFTR channel pore. We therefore
hypothesized that a chloride sensor exposed to the exter-
nal aqueous environment might exist within a region(s) of the
CFTR protein that modulates ATP release by responding to
changes in the extracellular concentration of Cl2.
A Chloride Sensor Within the CFTR Channel Pore 
Regulates ATP Release
Obvious candidate sites in the CFTR molecule that might
be capable of sensing the extracellular Cl2 concentration
are aqueous exposed basic residues within the CFTR
channel pore. We therefore characterized the effects of
arginine mutations R334W, R347P, and R347E on CFTR-
modulated ATP release. R347 has been implicated as a
predominant site for Cl2 binding that at least in part deter-
mines the halide selectivity of the channel pore (Anderson
et al., 1991). Mutations in R347 have also been shown to
alter the number of anions that can simultaneously occupy
the pore (Tabcharai et al., 1993). Comparison of halide
conductance and permeability of CFTR to the rate of
CFTR-mediated ATP release for these mutants suggests
that the properties of anion binding in the channel pore
may directly affect the activation of ATP efflux. For exam-
ple, the R347P mutant demonstrated minimal changes in
DGCl(cAMP), GBr/GCl, and PBr/PCl when compared with
wtCFTR (Table II). Although the rate of ATP release in
the presence of external Cl2 was approximately fourfold
lower for this mutant when compared with the wild
type, the halide dependence ratio of ATP release rates
(JATP[Br]/JATP[Cl] 5 0.13) was quite similar to that of
wtCFTR (JATP[Br]/JATP[Cl] 5 0.22). Thus, a mutation that
resulted in minimal alterations in the anion conductance
properties of the CFTR channel pore was associated with
minimal changes in the halide dependence of ATP release.
In contrast, the R347E mutation caused pronounced alter-
ations of both electrophysiologic as well as ATP release
properties of CFTR. The significant increase in GBr/GCl
when compared with wtCFTR is in agreement with previ-
ous studies (Anderson et al., 1991). Concomitantly, the
R347E mutation dramatically altered the halide depen-
dence of ATP efflux (JATP[Br]/JATP[Cl] 5 7.3) when com-
pared with wtCFTR (JATP[Br]/JATP[Cl] 5 0.22). These
analyses of the R347P and R347E mutations suggest that
the molecular interactions of Cl2 and Br2 within the chan-
nel pore likely influence activation of ATP efflux. The mu-
Figure 7. Halide dependence of CFTR-modulated ATP release
is mediated by a chloride sensor within the channel pore. Results
in A demonstrate the mean (6 SEM) relative light units pro-
duced after activation with 8-cpt-cAMP/forskolin and changes in
the extracellular halide concentration. The number of oocytes
(N) compiled for each mutant are given with the number of inde-
pendent experiments for wtCFTR 5 3, R347P 5 2, R334E 5 3,
R334W 5 2, and water 5 3. Although all mutants were not al-
ways evaluated at one time, CFTR and water-injected controls
were always performed alongside of mutants to confirm the in-
tegrity of ATP responses in the particular batch of oocytes. B de-
picts the mean (6 SEM) rate of ATP efflux during the last three
buffer conditions as calculated from the slope of relative light
units vs. time (for the 100-s reading) for each individual oocyte.
The halide selectivity of CFTR-modulated ATP release is com-
pared with the halide permeability (PBr/PCl) and conductance
(GBr/GCl) ratios for each of the mutants in C. Results depict the
mean (6 SEM) for each construct as determined from the indi-
vidual I/V curves (the number of oocytes analyzed are shown in
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tant R334W demonstrated no halide dependence in the
ATP efflux rates (JATP[Br]/JATP[Cl] 5 1.1) when compared
with wtCFTR, suggesting that multiple residues within the
CFTR channel pore may be involved in halide binding and
subsequent conformational changes necessary for activa-
tion of CFTR-modulated ATP release.
In summary, mutational analyses implicate basic resi-
dues R347 and R334 within the CFTR channel pore as im-
portant sites that contribute to the effects of extracellular
halides on CFTR-modulated ATP release. Because CFTR
is insufficient to promote ATP release, we hypothesize
that the properties of the Cl2 and Br2 binding sites within
the channel pore reflect those of a chloride sensor that de-
termines the extent of functional interaction between
CFTR and a second cofactor necessary to mediate ATP
release (Fig. 8). In wtCFTR, this sensor has a dependence
of Cl . Br. We hypothesize that mutations within the
channel pore that alter the affinity of Cl2 and/or Br2 bind-
ing are also responsible for changes in the halide depen-
dence of ATP efflux. An unexplained feature is the need
for both cAMP agonist stimulation and a change in extra-
cellular Cl2 concentration (from low to high external Cl2).
We believe that these conditions may be necessary to trap
CFTR in a particular conformation that is favorable for
activating the ATP release machinery (Fig. 8), and that
Cl2 binding within the channel pore may facilitate attain-
ment of this conformation. Why CFTR-modulated ATP
release is not seen in cAMP-stimulated oocytes bathed in
high external Cl2 without prior exposure to Cl2-free solu-
tions is currently unknown. However, this feature suggests
that CFTR can sense changes of external Cl2 concentra-
tion and respond by invoking structural changes necessary
for interaction with an ATP release pathway (Fig. 8). The
magnitude of such concentration changes may be ex-
tremely small (10Ð15 mM Cl2) as indicated by the sharp
relationship between ATP efflux and extracellular Cl2
concentration (Fig. 5).
Implications in CF Airways Disease
The mechanism(s) by which CFTR regulates ionic compo-
sition of surface airway fluid are only beginning to be un-
derstood. Several studies have demonstrated regulatory
affects of CFTR on other epithelial ion channels such as
Table III. Summary of Electrophysiologic Measurements on CFTR Mutants
Wild type R347P R347E R334W Mock
DGCl (cAMP) (ms) 121 6 35 125 6 28 5.3 6 2.1 32 6 20 20.61 6 0.62
(N 5 5) (N 5 5) (N 5 5) (N 5 8) (N 5 7)
GBr/GCl 0.93 6 0.01 1.12 6 0.01 2.36 6 0.23 1.12 6 0.03
(N 5 5) (N 5 5) (N 5 5) (N 5 8) 2
PBr/PCl 1.13 6 0.02 1.02 6 0.01 1.00 6 0.04 1.22 6 0.02
(N 5 5) (N 5 5) (N 5 5) (N 5 8) 2
JATP (Cl) 8.7 6 3.4 2.0 6 0.98 1.5 6 0.49 3.4 6 1.3 0.021 6 0.001
(N 5 15) (N 5 9) (N 5 11) (N 5 7) (N 5 15)
JATP (Br) 1.9 6 0.51 0.26 6 0.17 11.0 6 4.8 3.7 6 1.5 0.013 6 0.006
(N 5 15) (N 5 9) (N 5 11) (N 5 7) (N 5 15)
JATP (Br)/JATP (Cl) 0.22 0.13 7.3 1.1 2
CFTR cRNAs were injected into Xenopus oocytes and evaluated for both electrophysiologic and ATP release characteristics. DGCl (cAMP), change in Cl2 conductance in response
to IBMX/forskolin; GBr/GCl, halide conductance ratio; PBr/PCl, halide permeability ratio, JATP (Cl), rate of ATP efflux in the presence of extracellular Cl2 (pmoles ATP/min); JATP
(Br), rate of ATP efflux in the presence of extracellular Br2 (pmoles ATP/min); JATP (Br)/JATP (Cl), halide dependence ratio of ATP efflux. Values represent the Mean 6 SEM with
N 5 number of oocytes analyzed from two to three independent frogs.
Figure 8. Chloride sensor model for CFTR activation of ATP re-
lease. The proposed mechanism for CFTR-modulated ATP release
in Xenopus oocytes must fit several criteria. First, extracellular
Cl2 and cAMP agonist stimulation are necessary but not suffi-
cient to activate CFTR-modulated ATP release. Second, the fact
that not all batches of oocytes that demonstrated CFTR-modulated
Cl2 conductance were capable of ATP efflux, suggests that a co-
factor(s) (blue) is needed for CFTR-modulated ATP release
(CFTR is yellow). The dependency of CFTR-modulated ATP re-
lease on the external Cl2 concentration and the effects of mutagene-
sis of putative pore residues in CFTR suggest that Cl2 may bind
within the channel pore to activate structural changes in CFTR
necessary for the appropriate interactions with a cofactor(s)-
dependent ATP release pathway. This model also incorporates
the altered halide selectivity of CFTR mediated conductance (Cl 5
Br) and ATP efflux (Cl . Br) as dependent on the affinity for ha-
lide binding at the chloride sensor within the channel pore.The Journal of Cell Biology, Volume 143, 1998 656
ENaC and the ORCC (Egan et al., 1992; Gabriel et al., 1993;
Schweibert et al., 1995; Jovov et al., 1995; Grubb et al., 1994;
Chinet et al., 1994; Johnson et al., 1995; Hyde et al., 1993; Is-
mailov et al., 1996). Defects in the functional properties of
both the ORCC and ENaC have been observed in CF air-
ways disease (Guggino, 1993; Gabriel et al., 1993; Stutts et
al., 1995; Kunzelmann et al., 1997; Iwase et al., 1994). Pre-
vious studies have implicated CFTR-modulated ATP re-
lease as likely mechanisms by which CFTR regulates the
ORCC through P2U purinergic receptors pathways (Schwie-
bert et al., 1995). The relevance of this dysregulation in CF
airways disease is currently unknown, but may reflect one
potential mechanism by which CFTR regulates Cl2 trans-
port in the airways. Findings from the present study sug-
gest that CFTR can sense the extracellular Cl2 concentra-
tion in the airways and respond by activating ATP release
pathways, which may in turn be responsible for regulating
other channels in the apical membrane of epithelial cells.
Because the concentration of Cl2 necessary for activation
of CFTR-modulated ATP release is within the physiologic
range of the known Cl2 concentration in the airway (85Ð
130 mM; Smith et al., 1996; Gilljam et al., 1989; Joris et al.,
1993), we speculate that this regulatory function of CFTR
may act as a salt concentration sensor important in main-
taining airway electrolyte balance. Such mechanisms that
maintain the appropriate salt concentration in the airway
have important consequences on the antibacterial activity
of surface airway fluid (Smith et al., 1996).
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